A press release from skincare company Neuvera announces a new consumer guide comparing peptides and topical collagen in anti-aging skincare. The release was distributed through Plentisoft and carries a note that Business Insider's editorial team was not involved in creating it.

The distinction the guide draws is a real one. Collagen is a large structural protein, while peptides are short chains of amino acids, and the company's argument is that putting collagen on skin is not the same thing as using ingredients intended to support collagen-related processes.

The 500 Dalton problem

The guide leans on what the release calls the widely cited 500 Dalton rule in dermatological research, which suggests molecules generally need to sit below 500 Daltons to pass through the skin barrier passively. Intact collagen is a large protein and therefore faces what the release describes as substantial limitations when applied topically.

That is the most useful sentence in the whole announcement, and it is one a collagen cream brand would never write. Neuvera's own framing is that collagen-containing skincare is primarily for surface hydration and temporarily improving how skin looks and feels.

Where peptides sit

On peptides, the release is noticeably more careful than most marketing in this category. Some are described as studied for signaling processes associated with collagen and other skin components, with the hedge left intact, and it notes that effective topical delivery remains an important consideration.

The peptide used, its concentration, formulation and delivery system all influence results, according to the guide. Neuvera's own topical products use what it calls its patented Peptide G portfolio, and the company positions the two ingredient types as complementary rather than competing.

What the release does not contain

There is no trial, no outcome figure and no named researcher anywhere in the announcement. The only external data point is a citation of Euromonitor International's 2025 global beauty survey, which the release says found preventing signs of aging is now among the top five motivations for skincare purchases.

No sample size or ranking detail accompanies that survey figure. For a document whose stated purpose is helping consumers distinguish established research from formulation-specific findings and marketing claims, that is an awkward gap.

Bottom line

The molecular-size argument is sound and worth reading. What follows it is a company explaining why its own ingredient class is the better bet, and no published data has been offered to settle that.